HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 3.85 CAD 1.32% Market Closed
Market Cap: 122.4m CAD
Have any thoughts about
HLS Therapeutics Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one HLS stock under the Base Case scenario is 8.61 CAD. Compared to the current market price of 3.85 CAD, HLS Therapeutics Inc is Undervalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HLS Relative Value
Base Case
8.61 CAD
Undervaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
90
vs Industry
62
Median 3Y
2.1
Median 5Y
5.3
Industry
2.3
Forward
1.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-16.3
Industry
23
Forward
-4.3
More Details
10
P/OCF
P/OCF
Price to OCF
10
vs History
71
vs Industry
44
Median 3Y
10.1
Median 5Y
16.3
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
20
Median 3Y
15.6
Median 5Y
15.6
Industry
20
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
85
vs Industry
67
Median 3Y
1.2
Median 5Y
2
Industry
2.2
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
92
vs Industry
46
Median 3Y
3.1
Median 5Y
6.2
Industry
2.4
Forward
2.3
More Details
2.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.7
vs History
90
vs Industry
64
Median 3Y
3.4
Median 5Y
6.7
Industry
5
More Details
9.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.1
vs History
84
vs Industry
28
Median 3Y
12.5
Median 5Y
15
Industry
12.9
Forward
8.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-13.5
Median 5Y
-36.1
Industry
17.4
Forward
-12.5
More Details
15.4
EV/OCF
EV/OCF
Enterprise Value to OCF
15.4
vs History
63
vs Industry
34
Median 3Y
15.1
Median 5Y
18.4
Industry
14
More Details
15.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15.4
vs History
41
vs Industry
32
Median 3Y
14.7
Median 5Y
14
Industry
18.2
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
87
vs Industry
64
Median 3Y
1
Median 5Y
1.5
Industry
1.9
More Details

Multiples Across Competitors

HLS Competitors Multiples
HLS Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
HLS Therapeutics Inc
TSX:HLS
122.4m CAD 1.5 -3.9 9.1 -13.3
US
Mckesson Corp
NYSE:MCK
75B USD 0.2 29.6 17.6 20.6
US
Cencora Inc
NYSE:COR
46.4B USD 0.2 30.7 11.3 15.5
US
Amerisourcebergen Corp
LSE:0HF3
46.2B USD 0.2 30.6 11.3 15.4
US
Cardinal Health Inc
NYSE:CAH
29.7B USD 0.1 23.5 10.6 14.1
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD 0.7 28.3 12.6 18.6
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
62.4B HKD 0.1 6.8 1.7 2.1
CN
Huadong Medicine Co Ltd
SZSE:000963
57.5B CNY 1.4 17.9 13.6 13.6
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
57.1B CNY 0.2 14.2 9.1 9.1
IT
Amplifon SpA
MIL:AMP
5.7B EUR 2.4 36.6 11.8 24.6

See Also

Summary
HLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLS stock valuation using valuation multiples.
Wall Street Estimates
HLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 216,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.